nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2B6—Raloxifene—osteoporosis	0.0848	0.172	CbGbCtD
Promethazine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0819	0.166	CbGbCtD
Promethazine—CYP2C9—Estropipate—osteoporosis	0.0671	0.136	CbGbCtD
Promethazine—CYP2B6—Cholecalciferol—osteoporosis	0.0654	0.133	CbGbCtD
Promethazine—ABCB1—Ethinyl Estradiol—osteoporosis	0.042	0.0851	CbGbCtD
Promethazine—CYP2C9—Cholecalciferol—osteoporosis	0.0346	0.0701	CbGbCtD
Promethazine—CYP2D6—Cholecalciferol—osteoporosis	0.0316	0.0641	CbGbCtD
Promethazine—ABCB1—Conjugated Estrogens—osteoporosis	0.0308	0.0625	CbGbCtD
Promethazine—CYP2C9—Estradiol—osteoporosis	0.0279	0.0565	CbGbCtD
Promethazine—ABCB1—Estradiol—osteoporosis	0.027	0.0549	CbGbCtD
Promethazine—Loss of consciousness—Raloxifene—osteoporosis	0.000806	0.00302	CcSEcCtD
Promethazine—Anxiety—Estropipate—osteoporosis	0.000803	0.00301	CcSEcCtD
Promethazine—Palpitations—Ibandronate—osteoporosis	0.000802	0.003	CcSEcCtD
Promethazine—Tinnitus—Risedronate—osteoporosis	0.000801	0.003	CcSEcCtD
Promethazine—Depression—Conjugated Estrogens—osteoporosis	0.000798	0.00299	CcSEcCtD
Promethazine—Irritability—Estradiol—osteoporosis	0.000793	0.00297	CcSEcCtD
Promethazine—Dyspepsia—Etidronic acid—osteoporosis	0.000786	0.00294	CcSEcCtD
Promethazine—Agranulocytosis—Zoledronate—osteoporosis	0.000776	0.0029	CcSEcCtD
Promethazine—Oedema—Estropipate—osteoporosis	0.000773	0.00289	CcSEcCtD
Promethazine—Anaphylactic shock—Estropipate—osteoporosis	0.000773	0.00289	CcSEcCtD
Promethazine—Anxiety—Ibandronate—osteoporosis	0.00077	0.00288	CcSEcCtD
Promethazine—Convulsion—Calcitriol—osteoporosis	0.00077	0.00288	CcSEcCtD
Promethazine—Arrhythmia—Risedronate—osteoporosis	0.000768	0.00287	CcSEcCtD
Promethazine—Constipation—Etidronic acid—osteoporosis	0.000764	0.00286	CcSEcCtD
Promethazine—Bradycardia—Zoledronate—osteoporosis	0.00076	0.00284	CcSEcCtD
Promethazine—Dry mouth—Ibandronate—osteoporosis	0.000756	0.00283	CcSEcCtD
Promethazine—Anxiety—Calcitriol—osteoporosis	0.000754	0.00282	CcSEcCtD
Promethazine—Anaphylactic shock—Ibandronate—osteoporosis	0.000741	0.00277	CcSEcCtD
Promethazine—Dry mouth—Calcitriol—osteoporosis	0.00074	0.00277	CcSEcCtD
Promethazine—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000738	0.00276	CcSEcCtD
Promethazine—Shock—Raloxifene—osteoporosis	0.000736	0.00276	CcSEcCtD
Promethazine—Feeling abnormal—Etidronic acid—osteoporosis	0.000736	0.00275	CcSEcCtD
Promethazine—Thrombocytopenia—Raloxifene—osteoporosis	0.000733	0.00274	CcSEcCtD
Promethazine—Shock—Ibandronate—osteoporosis	0.000729	0.00273	CcSEcCtD
Promethazine—Anaphylactic shock—Calcitriol—osteoporosis	0.000725	0.00271	CcSEcCtD
Promethazine—Muscle spasms—Risedronate—osteoporosis	0.000719	0.00269	CcSEcCtD
Promethazine—Asthma—Estradiol—osteoporosis	0.000718	0.00269	CcSEcCtD
Promethazine—Erythema—Pamidronate—osteoporosis	0.000711	0.00266	CcSEcCtD
Promethazine—Insomnia—Estropipate—osteoporosis	0.000699	0.00261	CcSEcCtD
Promethazine—Tension—Pamidronate—osteoporosis	0.000698	0.00261	CcSEcCtD
Promethazine—Nervousness—Pamidronate—osteoporosis	0.000691	0.00258	CcSEcCtD
Promethazine—Somnolence—Estropipate—osteoporosis	0.000687	0.00257	CcSEcCtD
Promethazine—Muscle spasms—Pamidronate—osteoporosis	0.000684	0.00256	CcSEcCtD
Promethazine—Dyspepsia—Estropipate—osteoporosis	0.00068	0.00254	CcSEcCtD
Promethazine—Insomnia—Raloxifene—osteoporosis	0.000677	0.00253	CcSEcCtD
Promethazine—Syncope—Risedronate—osteoporosis	0.000671	0.00251	CcSEcCtD
Promethazine—Insomnia—Ibandronate—osteoporosis	0.00067	0.00251	CcSEcCtD
Promethazine—Dyspepsia—Alendronate—osteoporosis	0.00067	0.00251	CcSEcCtD
Promethazine—Arrhythmia—Zoledronate—osteoporosis	0.000667	0.00249	CcSEcCtD
Promethazine—Fatigue—Estropipate—osteoporosis	0.000666	0.00249	CcSEcCtD
Promethazine—Pain—Estropipate—osteoporosis	0.000661	0.00247	CcSEcCtD
Promethazine—Constipation—Estropipate—osteoporosis	0.000661	0.00247	CcSEcCtD
Promethazine—Dyspepsia—Raloxifene—osteoporosis	0.000659	0.00247	CcSEcCtD
Promethazine—Loss of consciousness—Risedronate—osteoporosis	0.000657	0.00246	CcSEcCtD
Promethazine—Insomnia—Calcitriol—osteoporosis	0.000656	0.00245	CcSEcCtD
Promethazine—Photosensitivity reaction—Estradiol—osteoporosis	0.000656	0.00245	CcSEcCtD
Promethazine—Agitation—Pamidronate—osteoporosis	0.000653	0.00245	CcSEcCtD
Promethazine—Dyspepsia—Ibandronate—osteoporosis	0.000652	0.00244	CcSEcCtD
Promethazine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000651	0.00244	CcSEcCtD
Promethazine—Pain—Alendronate—osteoporosis	0.000651	0.00244	CcSEcCtD
Promethazine—Constipation—Alendronate—osteoporosis	0.000651	0.00244	CcSEcCtD
Promethazine—Erythema—Zoledronate—osteoporosis	0.00065	0.00243	CcSEcCtD
Promethazine—Somnolence—Calcitriol—osteoporosis	0.000645	0.00241	CcSEcCtD
Promethazine—Decreased appetite—Ibandronate—osteoporosis	0.000644	0.00241	CcSEcCtD
Promethazine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000642	0.0024	CcSEcCtD
Promethazine—Pain—Raloxifene—osteoporosis	0.00064	0.00239	CcSEcCtD
Promethazine—Depression—Estradiol—osteoporosis	0.000639	0.00239	CcSEcCtD
Promethazine—Fatigue—Ibandronate—osteoporosis	0.000639	0.00239	CcSEcCtD
Promethazine—Syncope—Pamidronate—osteoporosis	0.000638	0.00239	CcSEcCtD
Promethazine—Leukopenia—Pamidronate—osteoporosis	0.000637	0.00238	CcSEcCtD
Promethazine—Anxiety—Risedronate—osteoporosis	0.000635	0.00238	CcSEcCtD
Promethazine—Pain—Ibandronate—osteoporosis	0.000633	0.00237	CcSEcCtD
Promethazine—Constipation—Ibandronate—osteoporosis	0.000633	0.00237	CcSEcCtD
Promethazine—Pruritus—Etidronic acid—osteoporosis	0.000632	0.00236	CcSEcCtD
Promethazine—Decreased appetite—Calcitriol—osteoporosis	0.00063	0.00236	CcSEcCtD
Promethazine—Feeling abnormal—Alendronate—osteoporosis	0.000627	0.00235	CcSEcCtD
Promethazine—Oedema—Ethinyl Estradiol—osteoporosis	0.000626	0.00234	CcSEcCtD
Promethazine—Erythema—Conjugated Estrogens—osteoporosis	0.000625	0.00234	CcSEcCtD
Promethazine—Loss of consciousness—Pamidronate—osteoporosis	0.000625	0.00234	CcSEcCtD
Promethazine—Muscle spasms—Zoledronate—osteoporosis	0.000624	0.00234	CcSEcCtD
Promethazine—Jaundice—Estradiol—osteoporosis	0.000624	0.00234	CcSEcCtD
Promethazine—Dry mouth—Risedronate—osteoporosis	0.000623	0.00233	CcSEcCtD
Promethazine—Pain—Calcitriol—osteoporosis	0.00062	0.00232	CcSEcCtD
Promethazine—Constipation—Calcitriol—osteoporosis	0.00062	0.00232	CcSEcCtD
Promethazine—Convulsion—Pamidronate—osteoporosis	0.000616	0.00231	CcSEcCtD
Promethazine—Tension—Conjugated Estrogens—osteoporosis	0.000614	0.0023	CcSEcCtD
Promethazine—Vision blurred—Zoledronate—osteoporosis	0.000612	0.00229	CcSEcCtD
Promethazine—Diarrhoea—Etidronic acid—osteoporosis	0.000611	0.00229	CcSEcCtD
Promethazine—Feeling abnormal—Ibandronate—osteoporosis	0.00061	0.00228	CcSEcCtD
Promethazine—Tremor—Zoledronate—osteoporosis	0.000609	0.00228	CcSEcCtD
Promethazine—Nervousness—Conjugated Estrogens—osteoporosis	0.000607	0.00227	CcSEcCtD
Promethazine—Anxiety—Pamidronate—osteoporosis	0.000603	0.00226	CcSEcCtD
Promethazine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000601	0.00225	CcSEcCtD
Promethazine—Shock—Risedronate—osteoporosis	0.000601	0.00225	CcSEcCtD
Promethazine—Agitation—Zoledronate—osteoporosis	0.000597	0.00223	CcSEcCtD
Promethazine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000589	0.00221	CcSEcCtD
Promethazine—Confusional state—Pamidronate—osteoporosis	0.000585	0.00219	CcSEcCtD
Promethazine—Syncope—Zoledronate—osteoporosis	0.000582	0.00218	CcSEcCtD
Promethazine—Leukopenia—Zoledronate—osteoporosis	0.000581	0.00218	CcSEcCtD
Promethazine—Anaphylactic shock—Pamidronate—osteoporosis	0.00058	0.00217	CcSEcCtD
Promethazine—Oedema—Pamidronate—osteoporosis	0.00058	0.00217	CcSEcCtD
Promethazine—Palpitations—Zoledronate—osteoporosis	0.000574	0.00215	CcSEcCtD
Promethazine—Shock—Pamidronate—osteoporosis	0.000571	0.00214	CcSEcCtD
Promethazine—Loss of consciousness—Zoledronate—osteoporosis	0.000571	0.00214	CcSEcCtD
Promethazine—Thrombocytopenia—Pamidronate—osteoporosis	0.000568	0.00213	CcSEcCtD
Promethazine—Tachycardia—Pamidronate—osteoporosis	0.000566	0.00212	CcSEcCtD
Promethazine—Rash—Etidronic acid—osteoporosis	0.000563	0.00211	CcSEcCtD
Promethazine—Convulsion—Zoledronate—osteoporosis	0.000563	0.00211	CcSEcCtD
Promethazine—Dermatitis—Etidronic acid—osteoporosis	0.000562	0.00211	CcSEcCtD
Promethazine—Syncope—Conjugated Estrogens—osteoporosis	0.000561	0.0021	CcSEcCtD
Promethazine—Headache—Etidronic acid—osteoporosis	0.000559	0.00209	CcSEcCtD
Promethazine—Asthenia—Estropipate—osteoporosis	0.000554	0.00207	CcSEcCtD
Promethazine—Palpitations—Conjugated Estrogens—osteoporosis	0.000553	0.00207	CcSEcCtD
Promethazine—Insomnia—Risedronate—osteoporosis	0.000552	0.00207	CcSEcCtD
Promethazine—Anxiety—Zoledronate—osteoporosis	0.000551	0.00206	CcSEcCtD
Promethazine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00055	0.00206	CcSEcCtD
Promethazine—Pruritus—Estropipate—osteoporosis	0.000547	0.00205	CcSEcCtD
Promethazine—Asthenia—Alendronate—osteoporosis	0.000546	0.00204	CcSEcCtD
Promethazine—Hypotension—Pamidronate—osteoporosis	0.000542	0.00203	CcSEcCtD
Promethazine—Convulsion—Conjugated Estrogens—osteoporosis	0.000542	0.00203	CcSEcCtD
Promethazine—Dry mouth—Zoledronate—osteoporosis	0.000541	0.00202	CcSEcCtD
Promethazine—Fatigue—Ethinyl Estradiol—osteoporosis	0.00054	0.00202	CcSEcCtD
Promethazine—Pruritus—Alendronate—osteoporosis	0.000538	0.00201	CcSEcCtD
Promethazine—Dyspepsia—Risedronate—osteoporosis	0.000537	0.00201	CcSEcCtD
Promethazine—Tinnitus—Estradiol—osteoporosis	0.000536	0.00201	CcSEcCtD
Promethazine—Constipation—Ethinyl Estradiol—osteoporosis	0.000535	0.002	CcSEcCtD
Promethazine—Confusional state—Zoledronate—osteoporosis	0.000535	0.002	CcSEcCtD
Promethazine—Asthenia—Ibandronate—osteoporosis	0.000531	0.00199	CcSEcCtD
Promethazine—Anxiety—Conjugated Estrogens—osteoporosis	0.000531	0.00199	CcSEcCtD
Promethazine—Oedema—Zoledronate—osteoporosis	0.00053	0.00198	CcSEcCtD
Promethazine—Anaphylactic shock—Zoledronate—osteoporosis	0.00053	0.00198	CcSEcCtD
Promethazine—Diarrhoea—Estropipate—osteoporosis	0.000529	0.00198	CcSEcCtD
Promethazine—Fatigue—Risedronate—osteoporosis	0.000526	0.00197	CcSEcCtD
Promethazine—Insomnia—Pamidronate—osteoporosis	0.000525	0.00196	CcSEcCtD
Promethazine—Pruritus—Ibandronate—osteoporosis	0.000524	0.00196	CcSEcCtD
Promethazine—Pain—Risedronate—osteoporosis	0.000522	0.00195	CcSEcCtD
Promethazine—Constipation—Risedronate—osteoporosis	0.000522	0.00195	CcSEcCtD
Promethazine—Shock—Zoledronate—osteoporosis	0.000522	0.00195	CcSEcCtD
Promethazine—Diarrhoea—Alendronate—osteoporosis	0.000521	0.00195	CcSEcCtD
Promethazine—Asthenia—Calcitriol—osteoporosis	0.00052	0.00195	CcSEcCtD
Promethazine—Thrombocytopenia—Zoledronate—osteoporosis	0.000519	0.00194	CcSEcCtD
Promethazine—Tachycardia—Zoledronate—osteoporosis	0.000517	0.00194	CcSEcCtD
Promethazine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000516	0.00193	CcSEcCtD
Promethazine—Somnolence—Pamidronate—osteoporosis	0.000516	0.00193	CcSEcCtD
Promethazine—Pruritus—Calcitriol—osteoporosis	0.000513	0.00192	CcSEcCtD
Promethazine—Diarrhoea—Raloxifene—osteoporosis	0.000512	0.00192	CcSEcCtD
Promethazine—Dyspepsia—Pamidronate—osteoporosis	0.000511	0.00191	CcSEcCtD
Promethazine—Dizziness—Estropipate—osteoporosis	0.000511	0.00191	CcSEcCtD
Promethazine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00051	0.00191	CcSEcCtD
Promethazine—Oedema—Conjugated Estrogens—osteoporosis	0.00051	0.00191	CcSEcCtD
Promethazine—Diarrhoea—Ibandronate—osteoporosis	0.000507	0.0019	CcSEcCtD
Promethazine—Decreased appetite—Pamidronate—osteoporosis	0.000504	0.00189	CcSEcCtD
Promethazine—Dizziness—Alendronate—osteoporosis	0.000503	0.00188	CcSEcCtD
Promethazine—Shock—Conjugated Estrogens—osteoporosis	0.000502	0.00188	CcSEcCtD
Promethazine—Erythema—Estradiol—osteoporosis	0.000501	0.00187	CcSEcCtD
Promethazine—Fatigue—Pamidronate—osteoporosis	0.0005	0.00187	CcSEcCtD
Promethazine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000498	0.00186	CcSEcCtD
Promethazine—Constipation—Pamidronate—osteoporosis	0.000496	0.00186	CcSEcCtD
Promethazine—Pain—Pamidronate—osteoporosis	0.000496	0.00186	CcSEcCtD
Promethazine—Diarrhoea—Calcitriol—osteoporosis	0.000496	0.00186	CcSEcCtD
Promethazine—Hypotension—Zoledronate—osteoporosis	0.000495	0.00185	CcSEcCtD
Promethazine—Dizziness—Raloxifene—osteoporosis	0.000495	0.00185	CcSEcCtD
Promethazine—Tension—Estradiol—osteoporosis	0.000491	0.00184	CcSEcCtD
Promethazine—Dizziness—Ibandronate—osteoporosis	0.00049	0.00183	CcSEcCtD
Promethazine—Rash—Estropipate—osteoporosis	0.000487	0.00182	CcSEcCtD
Promethazine—Dermatitis—Estropipate—osteoporosis	0.000487	0.00182	CcSEcCtD
Promethazine—Nervousness—Estradiol—osteoporosis	0.000486	0.00182	CcSEcCtD
Promethazine—Headache—Estropipate—osteoporosis	0.000484	0.00181	CcSEcCtD
Promethazine—Muscle spasms—Estradiol—osteoporosis	0.000481	0.0018	CcSEcCtD
Promethazine—Rash—Alendronate—osteoporosis	0.00048	0.0018	CcSEcCtD
Promethazine—Insomnia—Zoledronate—osteoporosis	0.000479	0.00179	CcSEcCtD
Promethazine—Dermatitis—Alendronate—osteoporosis	0.000479	0.00179	CcSEcCtD
Promethazine—Feeling abnormal—Pamidronate—osteoporosis	0.000478	0.00179	CcSEcCtD
Promethazine—Hypotension—Conjugated Estrogens—osteoporosis	0.000477	0.00179	CcSEcCtD
Promethazine—Headache—Alendronate—osteoporosis	0.000477	0.00178	CcSEcCtD
Promethazine—Rash—Raloxifene—osteoporosis	0.000472	0.00177	CcSEcCtD
Promethazine—Dermatitis—Raloxifene—osteoporosis	0.000471	0.00176	CcSEcCtD
Promethazine—Somnolence—Zoledronate—osteoporosis	0.000471	0.00176	CcSEcCtD
Promethazine—Tremor—Estradiol—osteoporosis	0.000469	0.00176	CcSEcCtD
Promethazine—Headache—Raloxifene—osteoporosis	0.000469	0.00175	CcSEcCtD
Promethazine—Rash—Ibandronate—osteoporosis	0.000467	0.00175	CcSEcCtD
Promethazine—Dermatitis—Ibandronate—osteoporosis	0.000467	0.00175	CcSEcCtD
Promethazine—Dyspepsia—Zoledronate—osteoporosis	0.000467	0.00175	CcSEcCtD
Promethazine—Headache—Ibandronate—osteoporosis	0.000464	0.00174	CcSEcCtD
Promethazine—Insomnia—Conjugated Estrogens—osteoporosis	0.000462	0.00173	CcSEcCtD
Promethazine—Decreased appetite—Zoledronate—osteoporosis	0.000461	0.00172	CcSEcCtD
Promethazine—Agitation—Estradiol—osteoporosis	0.00046	0.00172	CcSEcCtD
Promethazine—Rash—Calcitriol—osteoporosis	0.000457	0.00171	CcSEcCtD
Promethazine—Fatigue—Zoledronate—osteoporosis	0.000457	0.00171	CcSEcCtD
Promethazine—Dermatitis—Calcitriol—osteoporosis	0.000457	0.00171	CcSEcCtD
Promethazine—Headache—Calcitriol—osteoporosis	0.000454	0.0017	CcSEcCtD
Promethazine—Somnolence—Conjugated Estrogens—osteoporosis	0.000454	0.0017	CcSEcCtD
Promethazine—Pain—Zoledronate—osteoporosis	0.000453	0.0017	CcSEcCtD
Promethazine—Constipation—Zoledronate—osteoporosis	0.000453	0.0017	CcSEcCtD
Promethazine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000449	0.00168	CcSEcCtD
Promethazine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000449	0.00168	CcSEcCtD
Promethazine—Syncope—Estradiol—osteoporosis	0.000449	0.00168	CcSEcCtD
Promethazine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000444	0.00166	CcSEcCtD
Promethazine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000443	0.00166	CcSEcCtD
Promethazine—Palpitations—Estradiol—osteoporosis	0.000442	0.00166	CcSEcCtD
Promethazine—Fatigue—Conjugated Estrogens—osteoporosis	0.00044	0.00165	CcSEcCtD
Promethazine—Loss of consciousness—Estradiol—osteoporosis	0.00044	0.00165	CcSEcCtD
Promethazine—Asthenia—Risedronate—osteoporosis	0.000438	0.00164	CcSEcCtD
Promethazine—Feeling abnormal—Zoledronate—osteoporosis	0.000437	0.00163	CcSEcCtD
Promethazine—Constipation—Conjugated Estrogens—osteoporosis	0.000436	0.00163	CcSEcCtD
Promethazine—Pain—Conjugated Estrogens—osteoporosis	0.000436	0.00163	CcSEcCtD
Promethazine—Pruritus—Risedronate—osteoporosis	0.000432	0.00162	CcSEcCtD
Promethazine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000428	0.0016	CcSEcCtD
Promethazine—Anxiety—Estradiol—osteoporosis	0.000425	0.00159	CcSEcCtD
Promethazine—Diarrhoea—Risedronate—osteoporosis	0.000418	0.00156	CcSEcCtD
Promethazine—Dry mouth—Estradiol—osteoporosis	0.000417	0.00156	CcSEcCtD
Promethazine—Asthenia—Pamidronate—osteoporosis	0.000416	0.00156	CcSEcCtD
Promethazine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000414	0.00155	CcSEcCtD
Promethazine—Confusional state—Estradiol—osteoporosis	0.000412	0.00154	CcSEcCtD
Promethazine—Pruritus—Pamidronate—osteoporosis	0.000411	0.00154	CcSEcCtD
Promethazine—Anaphylactic shock—Estradiol—osteoporosis	0.000409	0.00153	CcSEcCtD
Promethazine—Oedema—Estradiol—osteoporosis	0.000409	0.00153	CcSEcCtD
Promethazine—Dizziness—Risedronate—osteoporosis	0.000404	0.00151	CcSEcCtD
Promethazine—Shock—Estradiol—osteoporosis	0.000402	0.0015	CcSEcCtD
Promethazine—Tachycardia—Estradiol—osteoporosis	0.000399	0.00149	CcSEcCtD
Promethazine—Diarrhoea—Pamidronate—osteoporosis	0.000397	0.00149	CcSEcCtD
Promethazine—Rash—Ethinyl Estradiol—osteoporosis	0.000395	0.00148	CcSEcCtD
Promethazine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000394	0.00148	CcSEcCtD
Promethazine—Headache—Ethinyl Estradiol—osteoporosis	0.000392	0.00147	CcSEcCtD
Promethazine—Rash—Risedronate—osteoporosis	0.000385	0.00144	CcSEcCtD
Promethazine—Dermatitis—Risedronate—osteoporosis	0.000385	0.00144	CcSEcCtD
Promethazine—Dizziness—Pamidronate—osteoporosis	0.000384	0.00144	CcSEcCtD
Promethazine—Headache—Risedronate—osteoporosis	0.000382	0.00143	CcSEcCtD
Promethazine—Asthenia—Zoledronate—osteoporosis	0.00038	0.00142	CcSEcCtD
Promethazine—Pruritus—Zoledronate—osteoporosis	0.000375	0.0014	CcSEcCtD
Promethazine—Insomnia—Estradiol—osteoporosis	0.000369	0.00138	CcSEcCtD
Promethazine—Asthenia—Conjugated Estrogens—osteoporosis	0.000366	0.00137	CcSEcCtD
Promethazine—Rash—Pamidronate—osteoporosis	0.000366	0.00137	CcSEcCtD
Promethazine—Dermatitis—Pamidronate—osteoporosis	0.000366	0.00137	CcSEcCtD
Promethazine—Headache—Pamidronate—osteoporosis	0.000364	0.00136	CcSEcCtD
Promethazine—Somnolence—Estradiol—osteoporosis	0.000363	0.00136	CcSEcCtD
Promethazine—Diarrhoea—Zoledronate—osteoporosis	0.000363	0.00136	CcSEcCtD
Promethazine—Pruritus—Conjugated Estrogens—osteoporosis	0.000361	0.00135	CcSEcCtD
Promethazine—Dyspepsia—Estradiol—osteoporosis	0.00036	0.00135	CcSEcCtD
Promethazine—Decreased appetite—Estradiol—osteoporosis	0.000355	0.00133	CcSEcCtD
Promethazine—Fatigue—Estradiol—osteoporosis	0.000352	0.00132	CcSEcCtD
Promethazine—Dizziness—Zoledronate—osteoporosis	0.000351	0.00131	CcSEcCtD
Promethazine—Pain—Estradiol—osteoporosis	0.000349	0.00131	CcSEcCtD
Promethazine—Constipation—Estradiol—osteoporosis	0.000349	0.00131	CcSEcCtD
Promethazine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000349	0.00131	CcSEcCtD
Promethazine—Dizziness—Conjugated Estrogens—osteoporosis	0.000338	0.00126	CcSEcCtD
Promethazine—Feeling abnormal—Estradiol—osteoporosis	0.000337	0.00126	CcSEcCtD
Promethazine—Rash—Zoledronate—osteoporosis	0.000334	0.00125	CcSEcCtD
Promethazine—Dermatitis—Zoledronate—osteoporosis	0.000334	0.00125	CcSEcCtD
Promethazine—Headache—Zoledronate—osteoporosis	0.000332	0.00124	CcSEcCtD
Promethazine—Rash—Conjugated Estrogens—osteoporosis	0.000322	0.0012	CcSEcCtD
Promethazine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000322	0.0012	CcSEcCtD
Promethazine—Headache—Conjugated Estrogens—osteoporosis	0.00032	0.0012	CcSEcCtD
Promethazine—Asthenia—Estradiol—osteoporosis	0.000293	0.0011	CcSEcCtD
Promethazine—Pruritus—Estradiol—osteoporosis	0.000289	0.00108	CcSEcCtD
Promethazine—Diarrhoea—Estradiol—osteoporosis	0.00028	0.00105	CcSEcCtD
Promethazine—Dizziness—Estradiol—osteoporosis	0.00027	0.00101	CcSEcCtD
Promethazine—Rash—Estradiol—osteoporosis	0.000258	0.000964	CcSEcCtD
Promethazine—Dermatitis—Estradiol—osteoporosis	0.000257	0.000963	CcSEcCtD
Promethazine—Headache—Estradiol—osteoporosis	0.000256	0.000958	CcSEcCtD
Promethazine—CALM1—Metabolism—CYP19A1—osteoporosis	1.84e-05	7.69e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CALCA—osteoporosis	1.83e-05	7.63e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.82e-05	7.59e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—ESR1—osteoporosis	1.81e-05	7.55e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ENO1—osteoporosis	1.81e-05	7.53e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—ADCY5—osteoporosis	1.8e-05	7.5e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—ADCY5—osteoporosis	1.8e-05	7.5e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PSMA5—osteoporosis	1.78e-05	7.42e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PSMA2—osteoporosis	1.78e-05	7.42e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CALCA—osteoporosis	1.77e-05	7.38e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CALCA—osteoporosis	1.77e-05	7.38e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IRS1—osteoporosis	1.77e-05	7.37e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IRS2—osteoporosis	1.76e-05	7.35e-05	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—MYC—osteoporosis	1.75e-05	7.31e-05	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—TGFB1—osteoporosis	1.75e-05	7.29e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—MTHFR—osteoporosis	1.71e-05	7.13e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MTHFR—osteoporosis	1.71e-05	7.13e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IRS2—osteoporosis	1.7e-05	7.11e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IRS2—osteoporosis	1.7e-05	7.11e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ENO1—osteoporosis	1.7e-05	7.1e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—POMC—osteoporosis	1.7e-05	7.1e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IRS1—osteoporosis	1.69e-05	7.06e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ENO1—osteoporosis	1.69e-05	7.04e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.68e-05	7e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.68e-05	7e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.66e-05	6.93e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.66e-05	6.93e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KL—osteoporosis	1.66e-05	6.93e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6R—osteoporosis	1.66e-05	6.92e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MTHFR—osteoporosis	1.65e-05	6.9e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MTHFR—osteoporosis	1.65e-05	6.9e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IGF1—osteoporosis	1.64e-05	6.83e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—POMC—osteoporosis	1.63e-05	6.8e-05	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—TGFB1—osteoporosis	1.63e-05	6.79e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—IRS2—osteoporosis	1.63e-05	6.78e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—POMC—osteoporosis	1.62e-05	6.76e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KL—osteoporosis	1.61e-05	6.7e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KL—osteoporosis	1.61e-05	6.7e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—ADCY5—osteoporosis	1.6e-05	6.67e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—GPX1—osteoporosis	1.59e-05	6.65e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.59e-05	6.65e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6R—osteoporosis	1.59e-05	6.63e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6R—osteoporosis	1.58e-05	6.59e-05	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—TGFB1—osteoporosis	1.58e-05	6.57e-05	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—TGFB1—osteoporosis	1.58e-05	6.57e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—IRS2—osteoporosis	1.57e-05	6.56e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—IRS2—osteoporosis	1.57e-05	6.56e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.57e-05	6.54e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—POMC—osteoporosis	1.57e-05	6.54e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—POMC—osteoporosis	1.57e-05	6.54e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IGF1—osteoporosis	1.57e-05	6.54e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.57e-05	6.53e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	1.56e-05	6.51e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—ADCY5—osteoporosis	1.56e-05	6.49e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	1.56e-05	6.48e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—GPX1—osteoporosis	1.55e-05	6.47e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.54e-05	6.43e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.54e-05	6.42e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IRS1—osteoporosis	1.54e-05	6.41e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.54e-05	6.4e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6R—osteoporosis	1.53e-05	6.38e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6R—osteoporosis	1.53e-05	6.38e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.52e-05	6.33e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SPP1—osteoporosis	1.51e-05	6.31e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SPP1—osteoporosis	1.51e-05	6.29e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—ADCY5—osteoporosis	1.51e-05	6.28e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—ADCY5—osteoporosis	1.51e-05	6.28e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SPP1—osteoporosis	1.5e-05	6.27e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—GPX1—osteoporosis	1.5e-05	6.26e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—GPX1—osteoporosis	1.5e-05	6.26e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.49e-05	6.21e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IRS1—osteoporosis	1.49e-05	6.2e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IRS1—osteoporosis	1.49e-05	6.2e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.49e-05	6.2e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—MTHFR—osteoporosis	1.47e-05	6.14e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6R—osteoporosis	1.44e-05	6.03e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.44e-05	6.02e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—MTHFR—osteoporosis	1.43e-05	5.97e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—IRS1—osteoporosis	1.42e-05	5.92e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6R—osteoporosis	1.4e-05	5.83e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6R—osteoporosis	1.4e-05	5.83e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.39e-05	5.82e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—MTHFR—osteoporosis	1.39e-05	5.78e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—MTHFR—osteoporosis	1.39e-05	5.78e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—IRS1—osteoporosis	1.37e-05	5.73e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—IRS1—osteoporosis	1.37e-05	5.73e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.37e-05	5.72e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IRS2—osteoporosis	1.37e-05	5.71e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—POMC—osteoporosis	1.37e-05	5.7e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IRS2—osteoporosis	1.36e-05	5.69e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—LEP—osteoporosis	1.36e-05	5.69e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.36e-05	5.68e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IRS2—osteoporosis	1.36e-05	5.67e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.35e-05	5.63e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.35e-05	5.62e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.34e-05	5.6e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.34e-05	5.6e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—LEP—osteoporosis	1.34e-05	5.59e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—LEP—osteoporosis	1.34e-05	5.57e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6R—osteoporosis	1.33e-05	5.56e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—LEP—osteoporosis	1.33e-05	5.55e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—LEP—osteoporosis	1.32e-05	5.5e-05	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—IL6—osteoporosis	1.32e-05	5.5e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.31e-05	5.48e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—ESR1—osteoporosis	1.3e-05	5.43e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ADCY5—osteoporosis	1.3e-05	5.43e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6R—osteoporosis	1.29e-05	5.38e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6R—osteoporosis	1.29e-05	5.38e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.28e-05	5.35e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ESR1—osteoporosis	1.28e-05	5.34e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ESR1—osteoporosis	1.28e-05	5.32e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ESR1—osteoporosis	1.27e-05	5.3e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SPP1—osteoporosis	1.26e-05	5.25e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ADCY5—osteoporosis	1.26e-05	5.25e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ADCY5—osteoporosis	1.26e-05	5.25e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.26e-05	5.25e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.26e-05	5.24e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—IL6—osteoporosis	1.25e-05	5.22e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SPP1—osteoporosis	1.22e-05	5.08e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SPP1—osteoporosis	1.22e-05	5.08e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IRS1—osteoporosis	1.22e-05	5.08e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—IL6—osteoporosis	1.2e-05	5e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.2e-05	5e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IRS1—osteoporosis	1.2e-05	4.99e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IRS1—osteoporosis	1.19e-05	4.97e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IRS1—osteoporosis	1.19e-05	4.95e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ADCY5—osteoporosis	1.18e-05	4.92e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—POMC—osteoporosis	1.18e-05	4.91e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.18e-05	4.91e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—GPX1—osteoporosis	1.18e-05	4.9e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.17e-05	4.89e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—POMC—osteoporosis	1.17e-05	4.89e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—POMC—osteoporosis	1.15e-05	4.81e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—POMC—osteoporosis	1.15e-05	4.8e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—POMC—osteoporosis	1.15e-05	4.79e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—POMC—osteoporosis	1.15e-05	4.78e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—POMC—osteoporosis	1.14e-05	4.77e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6R—osteoporosis	1.14e-05	4.77e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IRS2—osteoporosis	1.14e-05	4.75e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—POMC—osteoporosis	1.13e-05	4.72e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.13e-05	4.71e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IGF1—osteoporosis	1.13e-05	4.7e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.13e-05	4.69e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6R—osteoporosis	1.12e-05	4.68e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6R—osteoporosis	1.12e-05	4.67e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6R—osteoporosis	1.12e-05	4.65e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—LEP—osteoporosis	1.11e-05	4.65e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.11e-05	4.64e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.11e-05	4.63e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—GPX1—osteoporosis	1.11e-05	4.62e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—POMC—osteoporosis	1.11e-05	4.62e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—POMC—osteoporosis	1.11e-05	4.62e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IGF1—osteoporosis	1.11e-05	4.62e-05	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—IL6—osteoporosis	1.11e-05	4.61e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.1e-05	4.61e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IGF1—osteoporosis	1.1e-05	4.6e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ADCY5—osteoporosis	1.1e-05	4.6e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IRS2—osteoporosis	1.1e-05	4.6e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IRS2—osteoporosis	1.1e-05	4.6e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.1e-05	4.6e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IGF1—osteoporosis	1.1e-05	4.59e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL1B—osteoporosis	1.1e-05	4.58e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—GPX1—osteoporosis	1.1e-05	4.58e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.09e-05	4.54e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.09e-05	4.53e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—MTHFR—osteoporosis	1.09e-05	4.53e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—LEP—osteoporosis	1.08e-05	4.5e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—LEP—osteoporosis	1.08e-05	4.5e-05	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—IL6—osteoporosis	1.07e-05	4.46e-05	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—IL6—osteoporosis	1.07e-05	4.46e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ESR1—osteoporosis	1.06e-05	4.44e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL1B—osteoporosis	1.06e-05	4.43e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL1B—osteoporosis	1.06e-05	4.43e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ESR1—osteoporosis	1.03e-05	4.29e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ESR1—osteoporosis	1.03e-05	4.29e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—MTHFR—osteoporosis	1.02e-05	4.26e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—MTHFR—osteoporosis	1.01e-05	4.23e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IRS1—osteoporosis	9.95e-06	4.15e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MYC—osteoporosis	9.84e-06	4.1e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TGFB1—osteoporosis	9.81e-06	4.09e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IRS1—osteoporosis	9.62e-06	4.01e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IRS1—osteoporosis	9.62e-06	4.01e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—POMC—osteoporosis	9.58e-06	3.99e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MYC—osteoporosis	9.42e-06	3.93e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TGFB1—osteoporosis	9.4e-06	3.92e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6R—osteoporosis	9.34e-06	3.9e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—POMC—osteoporosis	9.26e-06	3.86e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—POMC—osteoporosis	9.26e-06	3.86e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IGF1—osteoporosis	9.21e-06	3.84e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6R—osteoporosis	9.04e-06	3.77e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6R—osteoporosis	9.04e-06	3.77e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IGF1—osteoporosis	8.91e-06	3.72e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IGF1—osteoporosis	8.91e-06	3.72e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—POMC—osteoporosis	8.68e-06	3.62e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—IL6—osteoporosis	8.62e-06	3.6e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—IL6—osteoporosis	8.49e-06	3.54e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—IL6—osteoporosis	8.47e-06	3.53e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—IL6—osteoporosis	8.44e-06	3.52e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—IL6—osteoporosis	8.41e-06	3.51e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—IL6—osteoporosis	8.33e-06	3.47e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	8.31e-06	3.47e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—POMC—osteoporosis	8.18e-06	3.41e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—POMC—osteoporosis	8.11e-06	3.38e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MYC—osteoporosis	7.91e-06	3.3e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—TGFB1—osteoporosis	7.89e-06	3.29e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—osteoporosis	7.65e-06	3.19e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—osteoporosis	7.65e-06	3.19e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFB1—osteoporosis	7.63e-06	3.18e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFB1—osteoporosis	7.63e-06	3.18e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—osteoporosis	7.4e-06	3.08e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—osteoporosis	7.08e-06	2.95e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—osteoporosis	7.04e-06	2.94e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—osteoporosis	6.81e-06	2.84e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—osteoporosis	6.81e-06	2.84e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—osteoporosis	6.78e-06	2.83e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TGFB1—osteoporosis	6.76e-06	2.82e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—osteoporosis	6.67e-06	2.78e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—osteoporosis	6.65e-06	2.77e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	6.65e-06	2.77e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TGFB1—osteoporosis	6.64e-06	2.77e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—osteoporosis	6.63e-06	2.77e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	6.62e-06	2.76e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—osteoporosis	6.61e-06	2.76e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	6.6e-06	2.75e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—osteoporosis	6.55e-06	2.73e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	6.53e-06	2.72e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—osteoporosis	6.53e-06	2.72e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	6.51e-06	2.72e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—osteoporosis	6.44e-06	2.68e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—osteoporosis	6.23e-06	2.6e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—osteoporosis	6.23e-06	2.6e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—osteoporosis	5.94e-06	2.48e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—osteoporosis	5.75e-06	2.4e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—osteoporosis	5.75e-06	2.4e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—osteoporosis	5.54e-06	2.31e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TGFB1—osteoporosis	5.52e-06	2.3e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—osteoporosis	5.36e-06	2.23e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—osteoporosis	5.36e-06	2.23e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TGFB1—osteoporosis	5.34e-06	2.23e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TGFB1—osteoporosis	5.34e-06	2.23e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—osteoporosis	5.09e-06	2.12e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—osteoporosis	5.01e-06	2.09e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—osteoporosis	5e-06	2.09e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—osteoporosis	4.99e-06	2.08e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—osteoporosis	4.97e-06	2.07e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—osteoporosis	4.92e-06	2.05e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—osteoporosis	4.91e-06	2.05e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—osteoporosis	4.16e-06	1.74e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—osteoporosis	4.03e-06	1.68e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—osteoporosis	4.03e-06	1.68e-05	CbGpPWpGaD
